"Disease Progression" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The worsening of a disease over time. This concept is most often used for chronic and incurable diseases where the stage of the disease is an important determinant of therapy and prognosis.
| Descriptor ID |
D018450
|
| MeSH Number(s) |
C23.550.291.656
|
| Concept/Terms |
Disease Progression- Disease Progression
- Disease Progressions
- Progression, Disease
- Progressions, Disease
|
Below are MeSH descriptors whose meaning is more general than "Disease Progression".
Below are MeSH descriptors whose meaning is more specific than "Disease Progression".
This graph shows the total number of publications written about "Disease Progression" by people in this website by year, and whether "Disease Progression" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 4 | 4 |
| 1996 | 0 | 7 | 7 |
| 1997 | 0 | 11 | 11 |
| 1998 | 0 | 18 | 18 |
| 1999 | 0 | 27 | 27 |
| 2000 | 0 | 21 | 21 |
| 2001 | 0 | 29 | 29 |
| 2002 | 0 | 24 | 24 |
| 2003 | 0 | 47 | 47 |
| 2004 | 0 | 33 | 33 |
| 2005 | 0 | 42 | 42 |
| 2006 | 0 | 43 | 43 |
| 2007 | 0 | 52 | 52 |
| 2008 | 0 | 46 | 46 |
| 2009 | 3 | 45 | 48 |
| 2010 | 3 | 61 | 64 |
| 2011 | 9 | 54 | 63 |
| 2012 | 5 | 64 | 69 |
| 2013 | 4 | 63 | 67 |
| 2014 | 6 | 64 | 70 |
| 2015 | 9 | 82 | 91 |
| 2016 | 5 | 66 | 71 |
| 2017 | 8 | 78 | 86 |
| 2018 | 6 | 85 | 91 |
| 2019 | 10 | 94 | 104 |
| 2020 | 5 | 80 | 85 |
| 2021 | 5 | 62 | 67 |
| 2022 | 0 | 39 | 39 |
| 2023 | 0 | 41 | 41 |
| 2024 | 18 | 32 | 50 |
| 2025 | 2 | 12 | 14 |
To return to the timeline,
click here.
Below are the most recent publications written about "Disease Progression" by people in Profiles.
-
Testosterone replacement therapy in men on active surveillance for prostate cancer. J Sex Med. 2025 Apr 08; 22(3):432-438.
-
Odronextamab monotherapy in R/R DLBCL after progression with CAR T-cell therapy: primary analysis of the ELM-1 study. Blood. 2025 Apr 03; 145(14):1498-1509.
-
Developing digital health technologies for frontotemporal degeneration. Alzheimers Dement. 2025 Apr; 21(4):e70082.
-
Characterization of hepatic pathology during azoxymethane-induced acute liver failure. World J Gastroenterol. 2025 Mar 28; 31(12):103952.
-
Effects of androgen modifying therapies on disease activity in older men with multiple sclerosis. J Neuroimmunol. 2025 Jun 15; 403:578589.
-
Spinocerebellar Ataxia Progression Measured with the Patient-Reported Outcome Measure of Ataxia. Mov Disord. 2025 May; 40(5):917-927.
-
IA-2A positivity increases risk of progression within and across established stages of type 1 diabetes. Diabetologia. 2025 May; 68(5):993-1004.
-
Dupilumab reduces acute exacerbations and improves lung function in patients with COPD with type 2 inflammation irrespective of body mass index, airflow obstruction, dyspnea, and exercise capacity index scores. Respir Med. 2025 May; 241:108015.
-
Progressive inner retinal neurodegeneration in non-proliferative macular telangiectasia type 2. Br J Ophthalmol. 2025 Feb 24; 109(3):401-407.
-
Study of the Association Between Menarche and Disease Course in Pediatric Multiple Sclerosis. Neurology. 2025 Feb 25; 104(4):e210213.